Mary Kay Inc. Partners With Dr. Jack Gilbert to Further Study Skin’s “Microbiome” and the Impact on the Aging Process

DALLAS–(BUSINESS WIRE)–Mary Kay Inc., one of the world’s leading skincare research companies, has announced a new partnership with Dr. Jack Gilbert, professor of pediatrics at the University of California San Diego School of Medicine and professor of microbial oceanography at UC San Diego Scripps Institution of Oceanography. Through the partnership, scientists at Mary Kay will … [Read more…]

Childhood Absence Epilepsy Treatment Market Report 2022-2027: High Prevalence of Epilepsy in Children and Rising Funding from Contract Research Organizations Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Childhood Absence Epilepsy Treatment Market Research Report by Drug (Lamotrigine, Phase 2 Drugs, and Valproate), Disease Type, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Childhood Absence Epilepsy Treatment Market size was estimated … [Read more…]

U.S. Acne Drugs Market to Reach $1.94 Billion by 2027 at a CAGR of 9.63% – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Acne Drugs Market Research Report by Acne Type (Comedonal, Cystic, and Inflammatory), Drug Class, Drug Type, Route of Administration, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The United States Acne Drugs Market size was estimated at USD 1,119.50 million in 2021, … [Read more…]

Monoclonal Antibodies for Oncology Global Market Report 2022: Featuring Key Players GlaxoSmithKline, AstraZeneca, Merck & Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Monoclonal Antibodies for Oncology: Global Markets” report has been added to ResearchAndMarkets.com’s offering. The current report provides detailed exposure of global monoclonal antibodies for the oncology market. This report highlights the current and future market potential of monoclonal antibodies for oncology treatment and includes a detailed analysis of the market’s drivers, challenges, and … [Read more…]

Latest Prescription Drug Price Negotiation Draft Takes Two Steps Back for Seniors

WASHINGTON–(BUSINESS WIRE)–#FacesofAcceleratedApproval–The Partnership to Fight Chronic Disease (PFCD) released the following statement today regarding the Prescription Drug Pricing Reform proposal aiming to lower drug prices through government negotiation under Medicare: “More than half of U.S. adults are living with at least one chronic condition and four in ten adults live with two or more. For … [Read more…]

Burke Neurological Institute Receives a $45 Million NIH Grant to Study a Vitamin B1 Precursor for Treatment of Alzheimer’s Disease in Multi-center Clinical Trial

WHITE PLAINS, N.Y.–(BUSINESS WIRE)–The Burke Neurological Institute (BNI) has received a five year award expected to total $45 million from the National Institutes of Health (NIH) to launch a large-scale, multi-center clinical trial to evaluate benfotiamine, a synthetic precursor of thiamine (vitamin B1), as a potentially effective therapy for mild Alzheimer’s disease (AD) or mild … [Read more…]

Hims & Hers Health, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 8, 2022

SAN FRANCISCO–(BUSINESS WIRE)–Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release its second quarter 2022 financial results on Monday, August 8, 2022 at 4:15 p.m. E.T., with a conference call to follow at 5:00 p.m. E.T. Conference … [Read more…]

National Institutes of Health Awards Aural Analytics $1.4M Grant

Aural Analytics’ Speech Vitals technology delivers clinical-grade speech analytics PHOENIX–(BUSINESS WIRE)–#AuralAnalytics–Aural Analytics, Inc., a leader in clinical-grade speech analytics, announced today it was awarded a $1.4 million grant from the National Institutes of Health. The grant supports Aural Analytics’ development of a tool speech-language pathologists can use to improve their clinical workflow. “The timing of … [Read more…]

Outlook on the Fractional Flow Reserve Global Market to 2027 – AI & ML Revolutionizing FFR-CT – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Fractional Flow Reserve Market – Global Outlook & Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The fractional flow reserve (FFR) is a gold standard for assessing coronary artery disease during invasive coronary angiography. The demand for FFR is increasing due to its increasing applications in improving patient outcomes, reducing stent insertion, … [Read more…]

MedX Announces Amendment to the Terms of Previously Announced Non-Brokered Private Placement of Series III Convertible Loan Notes

MISSISSAUGA, Ontario–(BUSINESS WIRE)–$MDX #SkinCancer—MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX) is pleased to announce that it has made an amendment to the terms of the non-brokered Private Placement previously announced in its News Release dated June 30, 2022. The private placement is being offered to accredited investors to raise up to $4 million … [Read more…]